Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
13(100.0%)
13Total
N/A(13)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT06765070Not ApplicableActive Not Recruiting

Efficacy and Usability of the EXPLORER Exoskeleton in Children With Neurodevelopmental Disorders in Natural Environments

Role: lead

NCT07159360Not ApplicableNot Yet Recruiting

Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

Role: lead

NCT06772077Not ApplicableRecruiting

Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients With Spinal Cord Injury

Role: lead

NCT06894160Not ApplicableNot Yet Recruiting

Safety and Usability of the EXPLORER Exoskeleton in Adults With Neuromuscular Diseases

Role: lead

NCT05551364Not ApplicableCompleted

Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy

Role: lead

NCT06167954Not ApplicableCompleted

Safety and Usability of a Robotic Gait Device for Children and Adolescents With Neurological or Neuromuscular Disease in Their Natural Environment

Role: lead

NCT05926635Active Not Recruiting

Efficacy of a Rehabilitation Program With the Pediatric Exoskeleton ATLAS 2030 in Pediatric Patients With Cerebral Palsy

Role: lead

NCT05914818Not ApplicableCompleted

Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease

Role: lead

NCT04813601Not ApplicableCompleted

Rehabilitative Effect of the Use of a Gait Exoskeleton in Patients With Neuromuscular Disease or Cerebral Palsy

Role: lead

NCT05265377Not ApplicableCompleted

Safety and Usability of the STELO Exoskeleton in People With Acquired Brain Injury and Spinal Cord Injury

Role: lead

NCT05544409Not ApplicableCompleted

MAKv1 Exoskeleton for TKA Patients: a Safety, Usability and Clinical Effects Trial of an Early Intervention

Role: lead

NCT05416034Not ApplicableCompleted

Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy

Role: lead

NCT04837144Not ApplicableCompleted

Evaluation of the Safety and Usability of the MAK Exoskeleton in Patients With Stroke

Role: lead

NCT04837157Not ApplicableCompleted

Evaluation of the Exoskeleton ATLAS 2030 as Robot-assisted Physical Therapy to Children With Neuromuscular Diseases

Role: lead

All 14 trials loaded